Levosert

Levonorgestrel, the active ingredient in Levosert, is a progestogen presented as a 52 mg intrauterine system (IUS) for intrauterine use. It delivers a steady low dose of levonorgestrel to provide long‑acting reversible contraception for women of reproductive age, through a single device placed by a qualified clinician.

GNH USA supplies Levosert as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to this intrauterine contraceptive system. Our distribution network ensures compliance with local regulatory requirements and timely delivery.

Levosert, containing levonorgestrel, is used in the hormonal contraceptive pathway to prevent pregnancy.

Contraception: provides continuous birth control for up to five years. Heavy menstrual bleeding: reduces menstrual blood loss and may improve dysmenorrhea. Endometrial protection: maintains a thin endometrium, lowering the risk of endometrial hyperplasia.

Levosert may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Irregular bleeding or spotting - Amenorrhea (absence of periods) - Cervical discharge - Pelvic or abdominal cramping - Headache

Serious or Rare Side Effects: - Uterine perforation during insertion or removal - Expulsion of the intrauterine system - Pelvic inflammatory disease or infection - Ectopic pregnancy if contraception fails - Severe allergic reaction (anaphylaxis)

Before insertion, clinicians should evaluate patients for contraindications and counsel on expected changes.

Screening: confirm absence of active pelvic infection, uterine anomalies, or malignancy. Pregnancy testing: ensure the patient is not pregnant at the time of insertion. Follow‑up: schedule a post‑insertion visit to verify correct placement. Bleeding patterns: advise that menstrual bleeding may become irregular, lighter, or cease. Removal: device should be removed by a qualified provider after the intended duration or if complications arise. Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levonorgestrel levels can be altered by other medicines, requiring attention to potential efficacy changes.

Major Interactions (Avoid): - Enzyme inducers such as rifampicin that markedly reduce levonorgestrel concentrations. - Antiepileptic drugs (e.g., carbamazepine, phenytoin) that may compromise contraceptive effectiveness.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole) that can increase levonorgestrel exposure. - Certain antiretrovirals (e.g., efavirenz) that may lower hormone levels. - Herbal supplements like St. John’s wort that may affect hormonal metabolism.